Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

XRAY

DENTSPLY Sirona Inc

Feb 13 • 04:00PM ET

12.95

+0.14 1.09 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: ALGN HSIC STE SYK PDCO BDX HOLX MTD ZM BIO

| Held by: IJH VTI VB VBR VXF MDY IJJ SCHA SPMD IWR

Index	-	P/E	-	EPS (ttm)	-4.43	Insider Own	0.65%	Shs Outstand	199.50M	Perf Week	-5.89%
Market Cap	2.58B	Forward P/E	8.76	EPS next Y	1.48	Insider Trans	-5.32%	Shs Float	198.26M	Perf Month	4.86%
Enterprise Value	4.70B	PEG	-	EPS next Q	0.28	Inst Own	99.50%	Short Float	7.32%	Perf Quarter	19.46%
Income	-882.00M	P/S	0.71	EPS this Y	-4.09%	Inst Trans	3.60%	Short Ratio	3.67	Perf Half Y	-6.63%
Sales	3.62B	P/B	1.75	EPS next Y	-7.73%	ROA	-14.37%	Short Interest	14.51M	Perf YTD	13.30%
Book/sh	7.41	P/C	7.12	EPS next 5Y	-0.38%	ROE	-44.44%	52W High	19.27 -32.80%	Perf Year	-31.01%
Cash/sh	1.82	P/FCF	32.30	EPS past 3/5Y	- -	ROIC	-24.64%	52W Low	9.85 31.47%	Perf 3Y	-64.90%
Dividend Est.	0.66 (5.06%)	EV/EBITDA	7.59	Sales past 3/5Y	-3.58% -1.20%	Gross Margin	51.10%	Volatility	4.37% 4.11%	Perf 5Y	-76.60%
Dividend TTM	0.64 (4.94%)	EV/Sales	1.30	EPS Y/Y TTM	-113.81%	Oper. Margin	7.48%	ATR (14)	0.53	Perf 10Y	-76.34%
Dividend Ex-Date	Dec 26, 2025	Quick Ratio	0.99	Sales Y/Y TTM	-7.08%	Profit Margin	-24.34%	RSI (14)	53.54	Recom	2.89
Dividend Gr. 3/5Y	14.17% 10.99%	Current Ratio	1.47	EPS Q/Q	12.91%	SMA20	1.41%	Beta	1.01	Target Price	12.75
Payout	-	Debt/Eq	1.68	Sales Q/Q	-4.94%	SMA50	7.10%	Rel Volume	1.68	Prev Close	12.81
Employees	14000	LT Debt/Eq	1.42	Earnings	Feb 26 AMC	SMA200	-4.70%	Avg Volume	3.96M	Price	12.95
IPO	Aug 12, 1987	Option/Short	Yes / Yes	EPS/Sales Surpr.	-17.37% 0.82%	Trades		Volume	6,654,255	Change	1.09%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-09-25	Initiated	Barclays	Underweight	$12
Nov-07-25	Downgrade	William Blair	Outperform → Mkt Perform
Apr-15-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$14
Mar-13-25	Downgrade	Needham	Buy → Hold
Feb-14-25	Initiated	Wells Fargo	Equal Weight	$20
Jan-23-25	Downgrade	Jefferies	Buy → Hold	$30 → $20
Jan-07-25	Downgrade	Evercore ISI	Outperform → In-line	$20
Dec-04-24	Initiated	Mizuho	Neutral	$21
Nov-07-24	Downgrade	Leerink Partners	Outperform → Market Perform
Oct-25-24	Reiterated	Needham	Buy	$34 → $29
Aug-20-24	Reiterated	Needham	Buy	$34
Feb-26-24	Initiated	Leerink Partners	Outperform	$42
Nov-16-23	Initiated	Needham	Buy	$35
Nov-10-23	Upgrade	William Blair	Mkt Perform → Outperform
Jan-12-23	Upgrade	William Blair	Underperform → Mkt Perform
Aug-05-22	Downgrade	William Blair	Mkt Perform → Underperform
Jun-02-22	Upgrade	UBS	Neutral → Buy	$58 → $47
Apr-20-22	Downgrade	William Blair	Outperform → Mkt Perform
Apr-20-22	Downgrade	Piper Sandler	Overweight → Neutral	$46
Apr-19-22	Downgrade	Robert W. Baird	Outperform → Neutral	$67 → $48

Show Previous Ratings

Feb-09-26 07:40AM	Becton Dickinson (BDX) Beats Q1 Earnings and Revenue Estimates (Zacks)
Feb-06-26 07:52PM	Analyst Report: DENTSPLY SIRONA Inc. (Morningstar Research) +9.82%
Feb-05-26 04:15PM	Dentsply Sirona to Host Fourth Quarter and Full Year Conference Call on February 26 (GlobeNewswire)
Feb-04-26 05:30PM	Lifevantage (LFVN) Q2 Earnings and Revenues Lag Estimates (Zacks)
Jan-28-26 11:03PM	Dentsply Sirona (XRAY): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
08:15AM	Loading…
Jan-26-26 08:15AM	Wellspect HealthCare Launches Surity Female External Catheter Improving Care for Women Living with Severe Urinary Incontinence (PR Newswire)
Jan-21-26 12:21PM	Dentsply Sirona (XRAY) Stock Is Up, What You Need To Know (StockStory) +5.73%
Jan-15-26 11:43AM	Halper Sadeh LLC Encourages Dentsply Sirona Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
Jan-14-26 08:00AM	Patterson Dental and Dentsply Sirona Renew U.S. Dental Technology Distribution Partnership (GlobeNewswire)
Jan-13-26 04:30PM	Dentsply Sirona and Benco Dental Announce Expanded Partnership to Include Dental Technology Solutions (GlobeNewswire)
08:00AM	Dentsply Sirona Appoints Donald Zurbay to Board of Directors (GlobeNewswire)
Jan-12-26 09:00AM	Dentsply Sirona Appoints Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization (GlobeNewswire)
Jan-08-26 07:44AM	Jim Cramer on DENTSPLY SIRONA: "I Think It Absolutely Represents Some Value Here" (Insider Monkey)
Jan-06-26 04:15PM	Dentsply Sirona to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +6.55%
03:06PM	Why Dentsply Sirona (XRAY) Stock Is Trading Up Today (StockStory)
10:34PM	Loading…
Dec-24-25 10:34PM	Dental Equipment & Technology Stocks Q3 Results: Benchmarking Dentsply Sirona (NASDAQ:XRAY) (StockStory)
Dec-15-25 08:00AM	Dentsply Sirona Declares Quarterly Cash Dividend (GlobeNewswire)
Dec-11-25 06:39AM	Is Align Technology Stock Underperforming the S&P 500? (Barchart)
Nov-12-25 08:27PM	3 Healthcare Stocks Topping a 2025 List of Dividend Yields (Motley Fool)
Nov-11-25 06:40AM	New Strong Sell Stocks for Nov. 11 (Zacks)
Nov-10-25 09:15AM	Unlocking Dentsply (XRAY) International Revenues: Trends, Surprises, and Prospects (Zacks)
Nov-07-25 10:15AM	Dentsply Sirona CFO departs after six-month tenure (CFO Dive)
Nov-06-25 04:01PM	Dentsply Sirona Inc (XRAY) Q3 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com) -12.68%
03:12PM	Analyst Report: DENTSPLY SIRONA Inc. (Morningstar Research)
11:36AM	Why Dentsply Sirona (XRAY) Shares Are Plunging Today (StockStory)
10:39AM	XRAY Stock Declines on Q3 Earnings Miss & Lower 2025 EPS View (Zacks)
10:00AM	Compared to Estimates, Dentsply (XRAY) Q3 Earnings: A Look at Key Metrics (Zacks)
09:15AM	Dentsply International (XRAY) Lags Q3 Earnings Estimates (Zacks)
08:14AM	Dentsply Sirona (NASDAQ:XRAY) Posts Better-Than-Expected Sales In Q3 But Stock Drops 10% (StockStory)
08:00AM	Dentsply Sirona Reports Third Quarter 2025 Results (GlobeNewswire)
10:21PM	Loading…
Nov-04-25 10:21PM	What To Expect From Dentsply Sirona's (XRAY) Q3 Earnings (StockStory)
08:39AM	DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock? (Zacks)
Oct-30-25 10:00AM	Earnings Preview: Dentsply International (XRAY) Q3 Earnings Expected to Decline (Zacks)
Oct-24-25 10:40AM	Halper Sadeh LLC Encourages Dentsply Sirona Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
Oct-15-25 02:01PM	Dentsply Sirona (XRAY) Stock Trades Up, Here Is Why (StockStory)
Oct-13-25 08:01AM	Heartland Value Fund is Monitoring Dentsply Sirona (XRAY) Amid a Deep Discount (Insider Monkey)
Oct-10-25 03:50PM	Dentsply Sirona, Acadia Healthcare, and Haemonetics Stocks Trade Down, What You Need To Know (StockStory)
Oct-08-25 04:15PM	Dentsply Sirona to Host Third Quarter Conference Call on November 6th (GlobeNewswire)
Oct-02-25 08:30AM	Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization (GlobeNewswire)
Sep-23-25 11:31PM	Spotting Winners: Dentsply Sirona (NASDAQ:XRAY) And Dental Equipment & Technology Stocks In Q2 (StockStory)
Sep-21-25 09:26PM	DENTSPLY SIRONA Inc. (XRAY) Presents Refined Strategy Roadmap At the Morgan Stanley 23rd Annual Global Healthcare Conference (Insider Monkey)
Sep-16-25 09:29AM	Dental Giant DENTSPLY SIRONA Inc. (XRAY) Keeps Wellspect Unit Amid Strong Market Potential (Insider Monkey)
Sep-10-25 09:02AM	Dentsply Sirona Retains Wellspect Following Strategic Review (Zacks)
Sep-08-25 08:30AM	Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives (GlobeNewswire)
12:03AM	3 Reasons to Avoid XRAY and 1 Stock to Buy Instead (StockStory)
Aug-26-25 04:30PM	Dentsply Sirona to Participate in Upcoming Investor Conferences (GlobeNewswire)
08:22AM	Cooper Companies Likely to Beat Q3 Earnings Estimate on Lens Demand (Zacks)
Aug-21-25 09:45AM	Is the Options Market Predicting a Spike in DENTSPLY Stock? (Zacks)
Aug-19-25 01:41PM	Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. (Barrons.com)
05:59AM	Medtronic to add two new directors after Elliott takes large stake (Reuters)
Aug-18-25 04:06AM	Dental CAD-CAM Market Forecast and Company Analysis Report 2025-2029, with 3Shape, Align Technology, Carestream Dental, Dentsply Sirona, Jensen Dental, Schutz Dental, and Yenadent (GlobeNewswire)
Aug-14-25 10:35AM	Dental Implants and Prosthetics Company Evaluation Report 2025 \| Institut Straumann, Envista, and Dentsply Sirona Lead with Innovation and Expansive Portfolios (GlobeNewswire)
Aug-11-25 09:15AM	International Markets and Dentsply (XRAY): A Deep Dive for Investors (Zacks)
Aug-08-25 09:45AM	Why Dentsply International (XRAY) is a Top Growth Stock for the Long-Term (Zacks)
07:25AM	Analyst Report: DENTSPLY SIRONA Inc. (Morningstar Research)
Aug-07-25 02:15PM	Dentsply Sirona Maintains Outlook Despite Sales Decline (Benzinga)
01:49PM	Dentsply Sirona's (NASDAQ:XRAY) Q2 Earnings Results: Revenue In Line With Expectations (StockStory)
11:06AM	XRAY Stock Rises on Q2 Earnings & Revenues Beat, Adjusted Margins Up (Zacks)
09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
09:30AM	Dentsply (XRAY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:15AM	Dentsply International (XRAY) Tops Q2 Earnings and Revenue Estimates (Zacks)
06:49AM	Dental Soft Tissue Regeneration Markets 2021-2024 & 2025-2031 with Analyst Recommendations - Developing Cost-effective, Faster-acting Regenerative Materials / Untapped Potential in Emerging Markets (GlobeNewswire)
06:00AM	Dentsply Sirona Reports Second Quarter 2025 Results (GlobeNewswire)
Aug-06-25 12:50PM	Countdown to the 9th MedDev eMarketing Summit 2025 (San Diego, CA, United States - August 7-8, 2025) (GlobeNewswire)
Aug-05-25 11:10PM	Dentsply Sirona (XRAY) Q2 Earnings Report Preview: What To Look For (StockStory)
Aug-04-25 11:40AM	XRAY or MMSI: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Should Value Investors Buy Dentsply Sirona (XRAY) Stock? (Zacks)
08:35AM	DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock? (Zacks)
Jul-31-25 10:00AM	Dentsply International (XRAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks) -7.50%
Jul-30-25 05:30PM	Align Technology (ALGN) Q2 Earnings and Revenues Lag Estimates (Zacks)
Jul-28-25 09:50AM	Here's Why Dentsply International (XRAY) is a Strong Momentum Stock (Zacks)
12:01AM	Dentsply Sirona (XRAY): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jul-22-25 11:16AM	Analyst Report: DENTSPLY SIRONA Inc. (Morningstar Research)
09:40AM	Here's Why Dentsply International (XRAY) is a Strong Value Stock (Zacks)
06:00AM	Globus promotes Keith Pfeil to CEO as former exec leaves for Dentsply (MedTech Dive)
Jul-21-25 04:07PM	ZimVie Doubles And Then Some On Its Second Takeover Deal (Investor's Business Daily)
03:04PM	Analyst Report: DENTSPLY SIRONA Inc. (Morningstar Research)
12:21PM	Dentsply Sirona (XRAY) Stock Is Up, What You Need To Know (StockStory)
08:30AM	Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer (GlobeNewswire)
Jul-18-25 11:40AM	XRAY vs. MMSI: Which Stock Is the Better Value Option? (Zacks)
09:40AM	Are Investors Undervaluing Dentsply Sirona (XRAY) Right Now? (Zacks)
09:28AM	US Dental Equipment Trends and Forecast Report 2025 \| Market to Reach $6.69 Billion by 2033 - Advancements in Dental Technology and Growing Oral Health Awareness Propel Expansion (GlobeNewswire)
Jul-16-25 12:26PM	Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now (Zacks)
Jul-14-25 09:26AM	Dental 3D Printing Market Forecast Study 2025, with Leading Dental Companies and Innovators BEGO, Dentsply Sirona, WhipMix, Straumann, Ivoclar, Formlabs, SprintRay, Asiga, and Shining3D (GlobeNewswire)
08:33AM	Dentsply Sirona's (XRAY) Long Road to Recovery Amid Economic Challenges (Insider Monkey)
Jul-10-25 08:30AM	Dentsply Sirona to Host Second Quarter Conference Call on August 7th (GlobeNewswire)
Jul-09-25 09:50AM	Why Dentsply International (XRAY) is a Top Momentum Stock for the Long-Term (Zacks)
Jul-03-25 09:40AM	Why Dentsply International (XRAY) is a Top Value Stock for the Long-Term (Zacks)
Jul-02-25 11:40AM	XRAY or MMSI: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Is Dentsply Sirona (XRAY) Stock Undervalued Right Now? (Zacks)
Jun-27-25 05:38AM	The Top 5 Analyst Questions From Dentsply Sirona's Q1 Earnings Call (StockStory)
Jun-25-25 11:31PM	Dental Equipment & Technology Q1 Earnings: Dentsply Sirona (NASDAQ:XRAY) Simply the Best (StockStory)
Jun-17-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jun-16-25 11:40AM	XRAY vs. MMSI: Which Stock Is the Better Value Option? (Zacks)
09:40AM	Should Value Investors Buy Dentsply Sirona (XRAY) Stock? (Zacks)
Jun-12-25 08:34AM	Is the Options Market Predicting a Spike in Dentsply Sirona Stock? (Zacks)
Jun-11-25 10:28AM	Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now (Zacks)
Jun-05-25 05:35PM	Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes (GlobeNewswire)
07:47AM	XRAY Q1 Earnings Call: Margin Gains Amid Tariff and Market Pressures (StockStory)
Jun-04-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment is engaged in designing, manufacturing, and selling dental technology and equipment products. The Essential Dental Solutions segment designs, manufactures, and sells value-added endodontic, restorative, and preventive consumable products. The Orthodontic and Implant Solutions segment designs, manufactures, and sells various digital implant systems and dental implant products. The Wellspect Healthcare segment designs, manufactures, and sells continence care solutions for management of both urinary and bowel dysfunction dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LUCIER GREGORY T	DIRECTOR	Dec 08 '25	Proposed Sale	11.10	82,200	912,420		Dec 11 08:16 PM
LUCIER GREGORY T	Director	Dec 08 '25	Sale	11.14	82,200	915,708	0	Dec 10 04:26 PM
VARON LESLIE F	Director	Nov 24 '25	Buy	10.71	9,337	99,999	57,343	Nov 25 05:26 PM
LUCIER GREGORY T	Director	Mar 03 '25	Buy	16.51	15,142	249,994	81,971	Mar 03 06:33 PM

Open in Screener

MRVI

Maravai LifeSciences Holdings Inc

Feb 13 • 04:00PM ET

2.96

-0.06 -1.99 %

Healthcare • Biotechnology • USA • NASD

MRVI Maravai LifeSciences Holdings Inc daily Stock Chart

Peers: TMO DHR ILMN BIO RGEN BMRN BIOX ACRS ALDX APLS

| Held by: VTI IWM VXF IWN IBB SCHA VTWO VHT DFAS PRFZ

Index	RUT	P/E	-	EPS (ttm)	-0.84	Insider Own	27.07%	Shs Outstand	144.72M	Perf Week	-5.73%
Market Cap	756.89M	Forward P/E	-	EPS next Y	-0.20	Insider Trans	0.83%	Shs Float	105.76M	Perf Month	-24.87%
Enterprise Value	1.07B	PEG	-	EPS next Q	-0.07	Inst Own	78.00%	Short Float	10.67%	Perf Quarter	-8.92%
Income	-121.24M	P/S	3.94	EPS this Y	-212.44%	Inst Trans	2.65%	Short Ratio	9.07	Perf Half Y	13.85%
Sales	192.28M	P/B	1.75	EPS next Y	34.96%	ROA	-11.40%	Short Interest	11.29M	Perf YTD	-8.92%
Book/sh	1.70	P/C	3.11	EPS next 5Y	-19.12%	ROE	-41.06%	52W High	4.40 -32.73%	Perf Year	-28.16%
Cash/sh	0.95	P/FCF	-	EPS past 3/5Y	- -64.27%	ROIC	-20.24%	52W Low	1.66 77.78%	Perf 3Y	-78.96%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-31.30% 12.61%	Gross Margin	19.61%	Volatility	4.77% 5.55%	Perf 5Y	-91.42%
Dividend TTM	-	EV/Sales	5.55	EPS Y/Y TTM	48.79%	Oper. Margin	-50.79%	ATR (14)	0.18	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.56	Sales Y/Y TTM	-30.56%	Profit Margin	-63.05%	RSI (14)	30.18	Recom	2.09
Dividend Gr. 3/5Y	- -	Current Ratio	5.29	EPS Q/Q	74.76%	SMA20	-13.21%	Beta	0.41	Target Price	3.93
Payout	-	Debt/Eq	1.50	Sales Q/Q	-36.15%	SMA50	-16.21%	Rel Volume	1.12	Prev Close	3.02
Employees	570	LT Debt/Eq	1.44	Earnings	Feb 25 AMC	SMA200	2.62%	Avg Volume	1.24M	Price	2.96
IPO	Nov 20, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.56% -15.08%	Trades		Volume	1,387,529	Change	-1.99%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-26-25	Downgrade	Robert W. Baird	Outperform → Neutral	$9 → $3
Dec-19-24	Initiated	Guggenheim	Neutral
Dec-05-24	Downgrade	Goldman	Neutral → Sell	$4.25
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Nov-08-24	Downgrade	William Blair	Outperform → Mkt Perform
Aug-28-24	Initiated	Wells Fargo	Overweight	$10
Aug-13-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$11 → $10
Apr-10-24	Initiated	Craig Hallum	Buy	$15
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy	$10 → $8
Aug-08-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-23-23	Downgrade	Credit Suisse	Outperform → Neutral	$18 → $14
May-09-23	Downgrade	Goldman	Buy → Neutral
Jan-05-23	Downgrade	UBS	Buy → Neutral	$20 → $16
Dec-14-22	Initiated	Deutsche Bank	Buy	$25
Dec-07-22	Initiated	RBC Capital Mkts	Outperform	$22
Nov-03-22	Downgrade	BofA Securities	Buy → Neutral	$32 → $17
Aug-25-22	Initiated	Credit Suisse	Outperform	$34
Aug-05-21	Resumed	Credit Suisse	Outperform	$44
Dec-16-20	Initiated	KeyBanc Capital Markets	Overweight	$33
Dec-15-20	Initiated	William Blair	Outperform

Show Previous Ratings

Feb-09-26 05:05PM	Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 (Business Wire)
Nov-10-25 08:00AM	Maravai LifeSciences Announces November 2025 Investor Conference Schedule (Business Wire) +8.01%
Nov-07-25 12:12AM	Maravai LifeSciences Holdings Inc (MRVI) Q3 2025 Earnings Call Highlights: Navigating ... (GuruFocus.com)
Nov-06-25 06:15PM	Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Maravai LifeSciences Reports Third Quarter 2025 Financial Results (Business Wire)
09:05AM	Loading…
Nov-04-25 09:05AM	AdaptHealth Corp. (AHCO) Misses Q3 Earnings Estimates (Zacks)
Oct-22-25 04:01PM	Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025 (Business Wire)
Aug-12-25 03:07AM	Maravai LifeSciences Holdings Inc (MRVI) Q2 2025 Earnings Call Highlights: Navigating ... (GuruFocus.com) +30.58%
Aug-11-25 07:00PM	Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -6.36%
04:05PM	Maravai LifeSciences Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-28-25 05:08PM	Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025 (GlobeNewswire) -6.42%
Jun-25-25 04:01PM	Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer (GlobeNewswire)
Jun-09-25 08:30AM	Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors (GlobeNewswire)
Jun-03-25 10:00AM	TriLink BioTechnologies and Quantoom Biosciences Sign License and Supply Agreement for CleanCap mRNA Capping Technology (Business Wire)
May-21-25 04:22PM	CORRECTION - Maravai LifeSciences Releases 2024 Sustainability Report (GlobeNewswire) -6.25%
04:05PM	Loading…
04:05PM	Maravai LifeSciences Releases 2024 Sustainability Report (GlobeNewswire)
May-20-25 08:00AM	TriLink BioTechnologies debuts its first mRNA synthesis kit with CleanCap capping technology; Celebrates launch with kit donations to top academic institutions (Business Wire) +10.60%
May-14-25 04:00PM	TriLink BioTechnologies and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines (Business Wire)
May-13-25 09:30AM	Q1 2025 Maravai LifeSciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
03:11AM	Maravai LifeSciences Holdings Inc (MRVI) Q1 2025 Earnings Call Highlights: Navigating Growth ... (GuruFocus.com)
May-12-25 05:20PM	Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +7.07%
04:06PM	Maravai Lifesciences Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-08-25 05:10PM	Jushi Holdings Inc. (JUSHF) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-07-25 07:10PM	MariMed Inc. (MRMD) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-05-25 05:47AM	MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI (PR Newswire)
May-01-25 05:20PM	Stryker (SYK) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:30AM	Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025 (GlobeNewswire)
Apr-24-25 12:27PM	Investors in Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights MRVI (GlobeNewswire)
Apr-22-25 05:45AM	Investors in Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights - MRVI (PR Newswire) +9.04%
Apr-16-25 06:10PM	Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations Hagens Berman (GlobeNewswire)
09:35AM	Loading…
Apr-15-25 09:35AM	MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI (PR Newswire)
Apr-14-25 01:13PM	Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations Hagens Berman (GlobeNewswire)
Apr-11-25 01:31PM	Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations Hagens Berman (GlobeNewswire)
Apr-10-25 11:34AM	QuidelOrtho (QDEL) Surges 10.1%: Is This an Indication of Further Gains? (Zacks) -8.25%
04:37AM	Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations - Hagens Berman (Newsfile)
Apr-04-25 02:34PM	Maravai LifeSciences: Upside Not Likely In 2025, But Company Can Survive (Seeking Alpha) -7.62%
Apr-03-25 06:21PM	MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI (PR Newswire)
Apr-01-25 01:23PM	Shareholders of Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights MRVI (GlobeNewswire)
Mar-26-25 11:10AM	Columbia Acorn Fund Q4 2024 Commentary (SeekingAlpha)
Mar-25-25 12:49PM	Is Maravai LifeSciences Holdings, Inc. (MRVI) the Top Stock to Buy According to 12 West Capital Management? (InsiderMonkey)
Mar-24-25 02:33PM	Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights MRVI (GlobeNewswire)
Mar-22-25 10:30AM	Maravai Lifesciences price target lowered to $5 from $10 at Stifel (TipRanks)
Mar-21-25 08:00PM	Maravai LifeSciences (MRVI) Q4 2024 Earnings Call Transcript (Motley Fool) -5.62%
01:43PM	Shareholders of Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights MRVI (GlobeNewswire)
Mar-20-25 09:00PM	Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2024 Earnings Conference Call Transcript (SeekingAlpha)
Mar-18-25 04:05PM	Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire) -5.81%
05:45AM	Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRVI (PR Newswire)
Mar-17-25 02:22AM	MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI (PR Newswire) +7.76%
Mar-16-25 09:32AM	3 Struggling Stocks Down More Than 50% This Year That Look Cheap But Come With Plenty of Risk (Motley Fool)
Mar-08-25 10:15AM	Maravai LifeSciences Holdings, Inc. (MRVI): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock? (Insider Monkey)
Feb-28-25 09:31AM	Maravai LifeSciences Holdings, Inc. (MRVI) Shares Fall 21% After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition - Hagens Berman (PR Newswire) +5.57%
Feb-27-25 06:37PM	Maravai LifeSciences Holdings, Inc. (MRVI) Acquires Officinae Bio to Enhance AI-Driven mRNA Development (Insider Monkey) -6.15%
Feb-25-25 06:00AM	Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call (GlobeNewswire) -21.70%
Feb-24-25 08:00AM	Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio (Business Wire)
Feb-04-25 04:01PM	TriLink BioTechnologies and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap mRNA Capping Technology (Business Wire)
Feb-03-25 06:00AM	TriLink BioTechnologies Partners with Avantor to Expand Nucleic Acid Solutions in Europe (Business Wire)
Jan-28-25 04:01PM	Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies (Business Wire) -8.55%
Jan-20-25 11:02PM	Maravai LifeSciences Holdings, Inc. (MRVI) Stock: An Under $5 Gem with Biggest Upside Potential (Insider Monkey)
Jan-08-25 04:10PM	Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue (GlobeNewswire) -20.88%
Dec-20-24 07:15AM	Maravai Lifesciences initiated with a Neutral at Guggenheim (TipRanks)
Dec-05-24 04:05PM	Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors (GlobeNewswire) -6.00%
Nov-12-24 08:05AM	Maravai LifeSciences Announces November 2024 Investor Conference Schedule (GlobeNewswire)
Nov-09-24 06:51AM	Maravai Lifesciences price target lowered to $9 from $10 at Baird (TipRanks)
Nov-08-24 02:20PM	Q3 2024 Maravai LifeSciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents) -35.27%
03:15AM	Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript (Motley Fool)
02:34AM	Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
Nov-07-24 04:01PM	Maravai LifeSciences Reports Third Quarter 2024 Financial Results (GlobeNewswire)
04:01PM	Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research (Business Wire)
Oct-15-24 04:05PM	Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024 (GlobeNewswire)
Oct-09-24 08:03AM	RGA Investment Advisors Highlights Maravai LifeSciences Holdings, Inc. (MRVI) in Q1 2024 Letter (Insider Monkey)
Sep-24-24 08:12AM	TriLink BioTechnologies & Alphazyme Collaborate to Launch New CleanScribe RNA Polymerase (Business Wire)
Aug-28-24 07:49AM	Cygnus Technologies and TriLink BioTechnologies Collaborate to Launch AccuRes Host Cell DNA Quantification Kits (Business Wire)
Aug-12-24 08:05AM	Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule (GlobeNewswire)
Aug-08-24 12:45AM	Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript (Motley Fool) -6.87%
Aug-07-24 04:05PM	Maravai LifeSciences Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-29-24 04:05PM	Maravai LifeSciences Appoints Trey Martin to Board of Directors (GlobeNewswire)
Jul-10-24 08:00AM	Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024 (GlobeNewswire)
Jul-02-24 04:00PM	Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report (GlobeNewswire)
Jun-20-24 09:15AM	Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics (ACCESSWIRE)
Jun-17-24 09:54AM	Here's Why RGAIA Considers Maravai LifeSciences Holdings' (MRVI) Margin Structure as the Best (Insider Monkey)
Jun-12-24 02:38AM	Steven Cohen's Strategic Acquisition in Maravai LifeSciences Holdings Inc (GuruFocus.com)
May-17-24 11:52AM	Maravai (MRVI) Advances in RNA Research With New Collaboration (Zacks)
May-13-24 08:00AM	TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center (Business Wire)
May-09-24 04:18PM	Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript (Insider Monkey) +11.16% +6.09%
04:05PM	Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule (GlobeNewswire)
10:53AM	UBS Raises Price Target on Maravai LifeSciences to $8.50 From $6.50, Maintains Neutral Rating (MT Newswires)
10:11AM	Baird Adjusts Price Target on Maravai LifeSciences to $10 From $8, Keeps Outperform Rating (MT Newswires)
04:02AM	Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: ... (GuruFocus.com)
03:15AM	Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript (Motley Fool)
May-08-24 08:57PM	MRVI Stock Earnings: Maravai LifeSciences Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	Maravai LifeSciences Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-30-24 07:31AM	TriLink BioTechnologies and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap mRNA Capping Technology (Business Wire)
Apr-18-24 07:36AM	TriLink BioTechnologies Announces New San Diego Facility for Late Phase mRNA Drug Substance Production (Business Wire)
Apr-10-24 04:05PM	Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024 (GlobeNewswire)
Mar-28-24 04:00PM	Dyadic Reports 2023 Full Year Results and Recent Company Progress (GlobeNewswire)
Mar-19-24 07:48AM	Should You Sell Maravai LifeSciences (MRVI)? (Insider Monkey)
Mar-12-24 04:15PM	Maravai LifeSciences Announces March 2024 Investor Conference Schedule (GlobeNewswire)
Feb-23-24 12:15PM	Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2023 Earnings Call Transcript (Insider Monkey) +63.60%
10:10AM	Q4 2023 Maravai LifeSciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-22-24 08:30PM	Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript (Motley Fool)

Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers' research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PRAHALAD MURALI	Former Director	Dec 23 '25	Proposed Sale	3.33	3,951	13,138		Dec 23 03:00 PM
Hopfield Jessica	Former Director	Dec 19 '25	Proposed Sale	3.48	53,951	187,526		Dec 19 04:38 PM
LUCIER GREGORY T	Director	Dec 05 '25	Buy	3.70	51,472	190,446	106,595	Dec 09 04:36 PM
LUCIER GREGORY T	Director	Dec 08 '25	Buy	3.67	48,528	178,098	155,123	Dec 09 04:36 PM
Brust Bernd	Chief Executive Officer	Nov 13 '25	Buy	3.25	216,212	702,689	466,771	Nov 17 04:48 PM
Brust Bernd	Chief Executive Officer	Nov 11 '25	Buy	3.24	157,201	509,331	157,201	Nov 13 05:27 PM
Brust Bernd	Chief Executive Officer	Nov 12 '25	Buy	3.21	93,358	299,679	250,559	Nov 13 05:27 PM

XRAY

DENTSPLY Sirona Inc

MRVI

Maravai LifeSciences Holdings Inc

Upgrade your FINVIZ experience